Verrica Pharmaceuticals Inc. (VRCA) Revenue 2021–2025
Verrica Pharmaceuticals Inc. (VRCA) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$35.6MFY2025 · since FY2021: $12.0M → $35.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $35.6M | +370.2% |
| FY2024 | $7.6M | +47.7% |
| FY2023 | $5.1M | -43.3% |
| FY2022 | $9.0M | -24.7% |
| FY2021 | $12.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VRCA financial trends
VRCA Net incomeVRCA Net marginVRCA Gross profitVRCA Gross marginVRCA Operating incomeVRCA Operating marginVRCA Operating cash flowVRCA Free cash flowVRCA Capital expendituresVRCA Return on equityVRCA Stock buybacksVRCA Dividends paidVRCA Total assetsVRCA Total liabilitiesVRCA Shareholders’ equityVRCA overview →